CTIX has back-up drugs, CRMX didn't. They focused

CTIX has back-up drugs, CRMX didn't. They focused on anti-virals, and it doesn't bode well for them that their lead drug failed. You never know, their other drug may do okay, but to me CTIX's market cap being half of theirs even after their failure shows how absurd our valuation is, and what an opportunity this is for anyone with some spare cash kicking around.

I wonder how many 2016 IRA contributions will be going into CTIX? Mine will be.